Document is current

Any future updates will be listed below

Concise Commentary: Gray Area—Underappreciated HCC Risk in Untreated “Gray Zone” and Immune-Tolerant CHB Patients

Crossref DOI link: https://doi.org/10.1007/s10620-025-09147-z

Published Online: 2025-06-09

Published Print: 2025-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark